Analysts Offer Predictions for USPH FY2024 Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH) – Equities research analysts at Barrington Research increased their FY2024 earnings estimates for U.S. Physical Therapy in a research note issued on Thursday, November 7th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings per share of $2.49 for the year, up from their previous estimate of $2.20. Barrington Research currently has a “Outperform” rating and a $108.00 price objective on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. Barrington Research also issued estimates for U.S. Physical Therapy’s Q3 2025 earnings at $0.62 EPS, FY2025 earnings at $2.52 EPS and FY2026 earnings at $2.88 EPS.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business had revenue of $167.19 million during the quarter, compared to the consensus estimate of $163.34 million. During the same period in the prior year, the firm earned $0.76 earnings per share. The business’s revenue for the quarter was up 10.4% on a year-over-year basis.

Other equities analysts have also issued reports about the company. Bank of America restated a “neutral” rating and set a $90.00 price target (down from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st.

U.S. Physical Therapy Stock Down 2.6 %

USPH opened at $92.17 on Monday. U.S. Physical Therapy has a 12 month low of $76.18 and a 12 month high of $113.63. The company has a current ratio of 1.78, a quick ratio of 1.88 and a debt-to-equity ratio of 0.27. The business’s 50-day moving average price is $83.92 and its 200-day moving average price is $91.25. The company has a market cap of $1.39 billion, a P/E ratio of 98.05, a P/E/G ratio of 4.40 and a beta of 1.38.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 15th will be issued a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 1.91%. The ex-dividend date is Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 187.23%.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Nancy Ham sold 1,172 shares of the company’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $96.72, for a total value of $113,355.84. Following the completion of the transaction, the director now directly owns 1,112 shares in the company, valued at approximately $107,552.64. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other U.S. Physical Therapy news, Director Nancy Ham sold 1,172 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $96.72, for a total transaction of $113,355.84. Following the sale, the director now directly owns 1,112 shares of the company’s stock, valued at approximately $107,552.64. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Kathleen A. Gilmartin bought 2,000 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The stock was purchased at an average cost of $86.09 per share, with a total value of $172,180.00. Following the transaction, the director now directly owns 18,904 shares in the company, valued at approximately $1,627,445.36. This represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have sold 6,620 shares of company stock worth $613,270. 1.70% of the stock is currently owned by insiders.

Institutional Trading of U.S. Physical Therapy

A number of hedge funds have recently modified their holdings of the business. Canada Pension Plan Investment Board bought a new stake in U.S. Physical Therapy during the second quarter worth about $28,000. Innealta Capital LLC bought a new stake in shares of U.S. Physical Therapy in the 2nd quarter worth approximately $30,000. Quest Partners LLC boosted its position in shares of U.S. Physical Therapy by 2,808.3% in the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock worth $32,000 after purchasing an additional 337 shares in the last quarter. Quarry LP grew its stake in shares of U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after buying an additional 478 shares during the last quarter. Finally, Ridgewood Investments LLC purchased a new position in U.S. Physical Therapy during the second quarter valued at $51,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.